BioCentury
ARTICLE | Clinical News

Biosimilar etanercept: Phase III data

July 18, 2016 7:00 AM UTC

Top-line data from the double-blind, international Phase III EGALITY trial in 531 patients with moderate to severe chronic plaque-type psoriasis showed that GP2015 met the primary endpoint of equivale...